GlaxoSmithKline (Ireland) Limited
- B01 - Agentes antitrombóticos
- INTEGRILIN solution for infusion 0.75 mg/ml
- INTEGRILIN solution for injection 2 mg/ml
- C02 - Antihipertensivos
- VOLIBRIS film-coated tablet 10 mg
- VOLIBRIS film-coated tablet 2.5 mg
- VOLIBRIS film-coated tablet 5 mg
- G04 - Urológicos
- AVODART capsule, soft 0.5 mg
- J01 - Antibacterianos para uso sistémico
- AUGMENTIN film-coated tablet 500 mg+125 mg
- AUGMENTIN film-coated tablet 875 mg+125 mg
- AUGMENTIN powder for oral suspension 200 mg/5 ml+28.5 mg/5 ml
- AUGMENTIN powder for oral suspension 400 mg/5 ml+57 mg/5 ml
- ZINACEF powder for solution for injection 1.5 g
- ZINACEF powder for solution for injection 250 mg
- ZINACEF powder for solution for injection 750 mg
- J05 - Antivirales de uso sistémico
- ZEFFIX film-coated tablet 100 mg
- ZEFFIX oral solution 5 mg/ml
- L01 - Antineoplásicos
- BLENREP powder and solvent for solution for infusion 100 mg
- JEMPERLI concentrate for solution for infusion 500 mg
- ZEJULA capsule, hard 100 mg
- ZEJULA film-coated tablet 100 mg
- L04 - Inmunosupresores
- BENLYSTA powder for solution for infusion 400 mg
- BENLYSTA U?PILDYTAME ?VIRK?TE solution for injection 200 mg
- BENLYSTA U?PILDYTAME ?VIRK?TIKLYJE solution for injection 200 mg
- N06 - Psicoanalépticos
- SEROXAT film-coated tablet 20 mg
- SEROXAT film-coated tablet 30 mg
- R01 - Preparaciones nasales
- AVAMYS nasal spray, suspension 27.5 µg/dose
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- ANORO ELLIPTA inhalation powder 22 µg/dose+55 µg/dose
- INCRUSE ELLIPTA inhalation powder, pre-dispensed 55 µg
- LAVENTAIR ELLIPTA inhalation powder 22 µg/dose+55 µg/dose
- RELVAR ELLIPTA inhalation powder, pre-dispensed 22 µg+184 µg
- RELVAR ELLIPTA inhalation powder, pre-dispensed 22 µg+92 µg
- REVINTY ELLIPTA inhalation powder, pre-dispensed 184 µg+22 µg
- REVINTY ELLIPTA inhalation powder, pre-dispensed 92 µg+22 µg